Vimarsana
Biggest News Aggregation in the World

Urs Spitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Urs Spitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Urs Spitz Today - Breaking & Trending Today

Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals - Vimarsana News

Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals

Biosynth, a supplier of critical raw materials to the life science industry, announced that it has acquired VIO Chemicals, a Zurich-based company with leading chemical R&D expertise and a glob ...

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pep - Vimarsana News

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pep

The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation.STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pe...

Expansion Underscores Exposure to Bioconjugation Solutions Market - Vimarsana News

Expansion Underscores Exposure to Bioconjugation Solutions Market

Critical raw materials supplier Biosynth (Staad, Switzerland) ) recently acquired German company celares, a leader in the development and manufacture of conjugate vaccines and bioconjugate drugs, activated PEGs and polymer-based drug delivery excipients, which will now be offered to the Swiss organisation’s existing pharma and diagnostics customer base, from GMP facilities located in Berlin, Germany. Click to read more...

Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals. - Vimarsana News

Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals.

Addition of UK based peptide and antibody production facilities expands peptides and biologics business in UK and Europe. Biosynth, a supplier of critical raw materials to the life science industry

Biosynth to Acquire Trinity Biotech's Life Sciences Supply Business for $30M - Vimarsana News

Biosynth to Acquire Trinity Biotech's Life Sciences Supply Business for $30M

Trinity said it is selling the business to focus on its core operations in diabetes care, decentralized patient monitoring, and diagnostic solutions.

Source: 360dx.com